The Limited Role of Alzheimer Disease Blood-Based Biomarkers in Primary Care

This Viewpoint examines the use of blood-based biomarkers to test for Alzheimer disease and outlines why they should not be the first or only tool used in screening for cognitive impairment.

Read the full article here

Related Articles